Navigation Links
Stemgent Announces Sponsorship of Harvard Stem Cell Institute Seminar Series;
Date:9/1/2009

BOSTON, Sept. 1 /PRNewswire/ -- Stemgent, Inc. announced today that it has pledged a financial gift to the Harvard Stem Cell Institute (HSCI) Seminar Series Fund in support of the HSCI 2009 - 2010 Seminar Series. Terms of the gift were not disclosed.

The HSCI Seminar Series is an educational program for the stem cell science community in which pioneers in the national and international realm of stem cell research, including many from the Harvard-affiliated senior faculty, present contemporary stem cell topics. Speakers are nominated by HSCI faculty and selected by the HSCI. The series are typically well attended and are recognized for fostering collaboration within the HSCI community as well as involving participation from the global stem cell scientific population.

"We're pleased to be able to fund this prestigious seminar series and we're very proud of our ongoing relationship with HSCI through our Scientific Advisory Board which includes Harvard's Lee Rubin and Doug Melton, " said Ian Ratcliffe, Stemgent's president and chief executive officer. " HSCI has a top-notch research team, displays a global scientific acumen and it's always a great pleasure to work with them."

Brock Reeve, Executive Director of HSCI, commented, "The HSCI Seminar Series is focused on enabling scientific interchange among experts in the stem cell field from around the world. HSCI is very pleased that Stemgent, a company focused on addressing the needs of stem cell scientists, has agreed to partner with us by supporting this series."

About the Harvard Stem Cell Institute

Founded in 2004, the Harvard Stem Cell Institute (HSCI) is a scientific collaborative that brings together researchers from across Harvard's many affiliated hospitals, institutes, and schools to accelerate stem cell science from the laboratory bench to the patient bedside. With 72 Principal
'/>"/>

SOURCE Stemgent, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Boston Scientific Announces Schedule for European Society of Cardiology Congress
2. ATS Medical Announces FDA Approval for a Landmark Clinical Investigation of the ATS 3f Aortic Bioprosthesis
3. Amgen Announces Top-Line Results of Trial to Reduce Cardiovascular Events With Aranesp(R) Therapy (TREAT) in CKD Patients With Type-2 Diabetes
4. ISTA Pharmaceuticals Announces Positive Preliminary Phase 3 Clinical Results to Support sNDA Filing for Once-Daily Xibrom(TM) 0.09%
5. IDEV(R) Technologies Announces First Patient Enrolled in Multi-Center Clinical Trial of SUPERA(R) PERipheral Stent
6. Phytomedics Inc. Announces Publication of the Phase 2b Clinical Trial Results of an Extract of the Chinese Herbal Remedy Tripterygium wilfordii Hook F in Rheumatoid Arthritis
7. Bionovo Announces Second Quarter 2009 Highlights and Financial Results
8. Eiger BioPharmaceuticals Announces Initiation of CLEAN-1 HCV Phase 1b Trial
9. NewCardio Announces Master Services Agreement With Dedicated Phase I
10. Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R)
11. Telik Announces Publication of Positive Phase 1 Results of a Multicenter Study of Ezatiostat Hydrochloride (TELINTRA(R), TLK199) Tablets In Patients With Myelodysplastic Syndrome
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... 22, 2014  Landauer, Inc. (NYSE: LDR ... measurement and monitoring, outsourced medical physics services and high ... E. Saxelby , its President and Chief Executive Officer, ... Officer and as a member of the Board of ... be replaced on an interim basis by Michael ...
(Date:8/21/2014)... -- Vermillion, Inc. (NASDAQ: VRML ), a multivariate ... has appointed Holly B. Bauzon as Vice ... Bauzon has a proven track record in both increasing ... companies. She has more than 20 years of healthcare ... the position of Director, Lab Services Sales and Managed ...
(Date:8/21/2014)... , Aug. 21, 2014 /CNW/ - Eisai Limited is ... introduction of the first-of-its-kind comic book available in ... has been designed specifically to educate children and their parents ... Canada affecting more than 300,000 Canadians. Eisai is ... care (hhc) , in which the patient is central – ...
Breaking Medicine Technology:Landauer, Inc. Announces Executive Management Change 2Vermillion Appoints Holly B. Bauzon as VP of Sales and Managed Markets 2Eisai Pleased to Support Canadian Epilepsy Alliance Comic Book that Teaches Children About Epilepsy 2
... Pharmaceuticals International, Inc. (NYSE: VRX ) (TSX: ... Cephalon, Inc. (NASDAQ: CEPH): In a letter ... stated that it "is presently undertaking a review of ... is focused on maximizing Cephalon shareholder value."  We know ...
... Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ) today announced ... to discuss first quarter 2011 financial results, as well as ... at 8:00 a.m. Eastern Time (5:00 a.m. Pacific Time; 2:00 ... ended March 31, 2011 will be released earlier that day. ...
Cached Medicine Technology:Valeant Pharmaceuticals Responds to Cephalon Board's Letter 2Valeant Pharmaceuticals Responds to Cephalon Board's Letter 3Valeant Pharmaceuticals Responds to Cephalon Board's Letter 4Onyx Pharmaceuticals Announces First Quarter 2011 Financial Results Teleconference and Webcast 2
(Date:8/22/2014)... (PRWEB) August 22, 2014 Dayton Children's Hospital ... tower as part of a $141 million campus renewal. ... care tower were unveiled to the public. , The ... plan that will create a campus that meets the needs ... These new care spaces will embody Dayton Children’s unique patient ...
(Date:8/22/2014)... artery stenting to open blockages in the kidney ... excluded from modern clinical trials, according to new ... Catheterization and Cardiovascular Interventions today by the ... University Hospitals Case Medical Center,s Sahil Parikh, MD, ... Medicine, Case Western Reserve University School of Medicine ...
(Date:8/22/2014)... (PRWEB) August 22, 2014 Menstrual leaks ... inventor from Sunrise, Fla., decided that there needed to ... Easy to use and producible in design variations, the ... caused by leaks, which avoids embarrassment and promotes peace ... conventional sanitary pads. , The original design was submitted ...
(Date:8/22/2014)... 2014 (HealthDay News) -- People who use reduced-nicotine cigarettes ... levels of nicotine, according to a new study. ... other smokers, the researchers say. The month-long study ... smoked regular cigarettes with nicotine emission levels of 1.2 ... switched to reduced-nicotine cigarettes for the next three weeks. ...
(Date:8/22/2014)... 2014 (HealthDay News) -- Many children get anxious or ... there are a number of ways that parents can ... suggests. The first step is to explain to ... protect their health, said Rita John, director of the ... School of Nursing in New York City. "Children ...
Breaking Medicine News(10 mins):Health News:Dayton Children's Hospital Breaks Ground on New, Eight-story Patient Care Tower 2Health News:Dayton Children's Hospital Breaks Ground on New, Eight-story Patient Care Tower 3Health News:Dayton Children's Hospital Breaks Ground on New, Eight-story Patient Care Tower 4Health News:Dayton Children's Hospital Breaks Ground on New, Eight-story Patient Care Tower 5Health News:UH Case Medical Center's Dr. Parikh authors SCAI paper on renal artery stenosis treatment 2Health News:UH Case Medical Center's Dr. Parikh authors SCAI paper on renal artery stenosis treatment 3Health News:Low-Nicotine Cigarettes May Not Lead to More Smoking 2Health News:Simple Steps Make Shots Less Scary for Kids, Nurse Says 2
... (HealthDay News) -- Researchers report that DNA analysis has led ... disease, along with its genetic cause. As described in ... of Medicine , the debilitating, painful and progressive disease is ... and feet of patients, and in the vascular network below ...
... Feb. 2 (HealthDay News) -- In families where dads ... be more supportive of each other,s parenting styles. ... may have more disagreements than couples in which mom ... State University study included 112 Midwestern couples with a ...
... WEDNESDAY, Feb 2 (HealthDay News) -- Victorious wrestlers have ... than their vanquished opponents, a new study finds. ... elite collegiate wrestling team before and after their matches. ... other hormones. In all the wrestlers, testosterone levels ...
... in the United States, account for a disproportionate share ... more than half of clinical trials exclude people based ... new study by Robert Wood Johnson Foundation (RWJF) Clinical ... findings are concerning because it means that doctors cannot ...
... FDA-approved hypertension medication may improve the results of ... report in the early edition of Proceedings ... General Hospital (MGH) investigators describe experiments showing that ... of collagen fibers that characterizes most solid tumors, ...
... available in French . Montreal, February 2, ... (LGB) are at far higher risk for severe mental health ... suggests that the stress of being rejected or victimized because ... and bisexuals. Recently published as a doctoral thesis ...
Cached Medicine News:Health News:Scientists Discover Rare Vascular Disease 2Health News:Parents Have Stronger Relationship When Dad Plays With Kids 2Health News:Older adults often excluded from clinical trials 2Health News:Generic drug may improve the effectiveness of cancer nanotherapies 2Health News:Physiological impacts of homophobia 2Health News:Physiological impacts of homophobia 3
The CSV-1000ETDRS10% test face presents the standard ETDRS test at a contrast level of 10%. This test is widely used in clinical studies for the evaluation of refractive surgery and contact lenses....
... The CSV-1000S test face is widely used ... evaluation. This test presents standard visual acuity from ... (6 and 12 cycles/degree) and a real-world driver's ... cataract documentation as it provides a standard acuity ...
Contrast sensitivity testing, glare sensitivity testing and ETDRS acuity testing are provided in the self standardized CSV-1000 instrument. Patented photocell circuitry automatically monitors and cal...
... those involved with healthcare decisions to keep ... evidence in their field of interest - ... as the volume of evidence increases. Cochrane ... best single source available for continually updated ...
Medicine Products: